{"organizations": [], "uuid": "5f22788d0a1adc757f52f977590ea2d46343ac56", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-pernix-therapeutics-announces-part/brief-pernix-therapeutics-announces-participation-in-lead-bid-worldwide-rights-of-contrave-idUSASC09WU6", "country": "US", "domain_rank": 408, "title": "BRIEF-Pernix Therapeutics Announces Participation In Lead Bid Worldwide Rights Of Contrave", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-23T18:36:00.000+03:00", "replies_count": 0, "uuid": "5f22788d0a1adc757f52f977590ea2d46343ac56"}, "author": "", "url": "https://www.reuters.com/article/brief-pernix-therapeutics-announces-part/brief-pernix-therapeutics-announces-participation-in-lead-bid-worldwide-rights-of-contrave-idUSASC09WU6", "ord_in_thread": 0, "title": "BRIEF-Pernix Therapeutics Announces Participation In Lead Bid Worldwide Rights Of Contrave", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "pernix therapeutics holdings inc", "sentiment": "none"}, {"name": "lead bid worldwide rights of contrave reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "pernix therapeutics holdings", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 23, 2018 / 3:36 PM / Updated 8 minutes ago BRIEF-Pernix Therapeutics Announces Participation In Lead Bid Worldwide Rights Of Contrave Reuters Staff 1 Min Read \nApril 23 (Reuters) - Pernix Therapeutics Holdings Inc : \n* PERNIX THERAPEUTICS ANNOUNCES PARTICIPATION IN LEAD BID FOR ACQUISITION OF WORLDWIDE RIGHTS TO CONTRAVE® FOR WEIGHT LOSS \n* PERNIX THERAPEUTICS HOLDINGS - TO PARTICIPATE IN INVESTOR GROUP THAT ENTERED INTO “STALKING HORSE” ASSET PURCHASE DEAL TO ACQUIRE SOME ASSETS OF OREXIGEN THERAPEUTICS \n* PERNIX THERAPEUTICS HOLDINGS - WOULD CONTRIBUTE 10% OF CAPITAL REQUIRED TO FUND PURCHASE PRICE OF DEAL, OR $7.5 MILLION \n* PERNIX THERAPEUTICS - WOULD CONTRIBUTE 10% OF CAPITAL REQUIRED TO FUND PURCHASE PRICE, OR $7.5 MILLION, FUNDED THROUGH DRAW UNDER EXISTING DELAYED DRAW TERM LOAN FACILITY Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-23T18:36:00.000+03:00", "crawled": "2018-04-23T18:59:39.044+03:00", "highlightTitle": ""}